TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0110
+0.0005 (4.76%)
At close: Sep 12, 2025
TrivarX Market Cap
TrivarX has a market cap or net worth of 6.82 million as of September 17, 2025. Its market cap has decreased by -34.51% in one year.
Market Cap
6.82M
Enterprise Value
5.74M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since July 2, 2001, TrivarX's market cap has decreased from 11.57M to 6.82M, a decrease of -41.06%. That is a compound annual growth rate of -2.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 6.82M | -8.33% |
| Dec 30, 2024 | 7.44M | -26.66% |
| Dec 29, 2023 | 10.14M | 52.72% |
| Dec 28, 2022 | 6.64M | -41.41% |
| Dec 30, 2021 | 11.34M | 5.14% |
| Dec 31, 2020 | 10.78M | 8.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 99.05B |
| Pro Medicus | 31.45B |
| Cochlear | 19.80B |
| Sonic Healthcare | 11.11B |
| Ramsay Health Care | 7.71B |
| Ansell | 4.89B |
| Telix Pharmaceuticals | 4.77B |
| Mesoblast | 3.00B |